%20Lopes_Emily%20W.jpg)
Emily Walsh Lopes, MD, MPH
Dr. Emily Lopes is a Physician Investigator in the CTEU, a gastroenterologist specializing in inflammatory bowel disease (IBD) at MGH, and an Instructor of Medicine at HMS. Dr. Lopes earned her MD from New York University School of Medicine. She completed her internal medicine residency, chief residency, general gastroenterology fellowship, and advanced IBD fellowship at MGH. She completed her MPH in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. Her research interests include understanding how dietary, lifestyle, and genetic factors influence the development and course of inflammatory bowel disease, as well as methods for studying disease prevention of IBD in high-risk individuals such as first-degree relatives of those with IBD. Her research has been funded by the American College of Gastroenterology and National Institutes of Health (NIH).
​
Projects
Lifestyle factors for the prevention of Crohn’s disease in unaffected first-degree relatives: A target trial
We are exploring the causal relationship between adherence to low-risk dietary and lifestyle factors and the risk of Crohn’s disease in unaffected first-degree relatives in the Nurses’ Health Study (NHS), NHSII, Health Professionals Follow-up Study (HPFS), and Growing Up Today Study (GUTS) cohorts (Lopes).
Personalized risk estimation for Crohn’s disease (PRE-Crohn's Study): Implementation and feasibility
We are studying if personalized risk disclosure and risk-factor education using a web-based module can modify behaviors and biomarkers associated with Crohn’s disease development in first-degree relatives of patients with inflammatory bowel disease (Lopes).
Family members at Increased-risk for Developing IBD (FIND-IBD)
This research cohort follows unaffected first-degree relatives of those with inflammatory bowel disease (IBD) over time, to better understand if their behaviors, diet, and biomarkers can help us predict who gets IBD and if we can prevent IBD development in these high-risk individuals.
​
Key Publications
​